Powered Morcellator Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Disposable and Reposable Powered Morcellators

Global Powered Morcellator Market Report to 2032

The global powered morcellator market was valued at just under $100 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching over $120 million by 2032.

This comprehensive report covers the global market for powered morcellators, including disposable and reposable powered morcellators used across gynecological, urological and select general surgical procedures.

The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Growth in this market is supported by the continued need to remove large tissue specimens through small laparoscopic incisions. However, adoption remains shaped by risk perception, surgeon training and the need for containment-focused workflows.

Market Overview

The global powered morcellator market includes devices used to fragment large tissue specimens during minimally invasive surgery. These products allow surgeons to remove tissue through small laparoscopic incisions without converting to a larger open incision.

Powered morcellators are used mainly in gynecological and urological procedures, with select use in general surgery. They are relevant in cases where organs or tissue specimens are too large to remove intact through standard laparoscopic access sites.

The market includes disposable and reposable powered morcellators. Disposable systems offer simplified logistics and reduced reprocessing requirements, while reposable systems combine reusable components with disposable elements such as blades to support cost control.

Technological development in this market is focused less on expanding procedure volume and more on containment, system integration and workflow efficiency. Manufacturers are emphasizing compatibility with containment systems and improved visualization to reduce perceived risks and support continued use in minimally invasive surgery.

Market Drivers

Use of morcellation across different specialties remains the main driver of the powered morcellator market. Powered morcellators enable extraction of large tissue specimens through small laparoscopic incisions, typically ranging from 5 to 15 mm. Organs such as the uterus or kidney often exceed these incision sizes and require tissue fragmentation to maintain a minimally invasive approach.

Powered morcellators, generally ranging from 12 to 20 mm in diameter, allow specimen removal without enlarging the incision. This helps preserve the clinical benefits of laparoscopy, including smaller incisions, faster recovery and lower surgical trauma compared with open surgery.

The ongoing preference for minimally invasive surgery continues to support baseline demand. As laparoscopic techniques remain important in gynecology and urology, powered morcellators remain necessary in selected procedures where intact specimen extraction is not feasible. This demand is focused rather than broad, but it continues to support steady market value over the forecast period.

Market Limiters

Alternative procedures limit demand in certain gynecological cases. Less invasive options, including medical management and endometrial ablation, may reduce the need for surgery in lower-severity indications. However, these alternatives have a limited overall impact on the powered morcellator market because morcellation is usually used in higher-complexity surgical procedures.

Surgeon training and risk aversion are more significant barriers. Adoption of powered morcellators is closely tied to training, institutional policy and surgeon risk tolerance. Surgeons trained before heightened regulatory scrutiny, or those with extensive experience in laparoscopic-assisted vaginal hysterectomy and total laparoscopic hysterectomy, are more likely to continue using morcellation when appropriate.

Newer surgeons may avoid powered morcellation due to perceived medico-legal risk. This limits broader adoption and makes the market dependent on experienced users, institutional protocols and the availability of risk mitigation strategies such as containment systems. As a result, growth remains modest despite the continued role of morcellation in selected minimally invasive procedures.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
• Qualitative coverage: Market drivers and limiters, market size and growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Data types included: Unit sales, average selling prices, market size and growth trends, market drivers and limiters, market forecasts through 2032, historical data, recent mergers and acquisitions, company profiles and product portfolios.
• Method note: Market revenue is modeled using unit sales and average selling prices, with segmentation by usage type used to assess demand across disposable and reposable powered morcellators.

The report is designed to help readers evaluate how minimally invasive surgery, containment strategies, surgeon training, risk perception and procedural alternatives are shaping the global powered morcellator market.

Markets Covered and Segmentation

Powered Morcellator Market

• Usage: Disposable and reposable.

Disposable powered morcellators are used to support specimen fragmentation while simplifying per-case logistics and reducing reprocessing requirements.

Reposable powered morcellators combine reusable components with disposable elements, such as blades, to balance performance, cost control and operating room workflow needs.

Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Competitive Analysis

LiNA Medical was the leader in the global disposable powered morcellator market and the overall global powered morcellator market in 2025. The Polish company has made its XCISE(TM) powered morcellators a widely recognized product line globally. Its leadership is supported by a strong disposable product position and continued relevance in gynecological and other minimally invasive procedures requiring tissue fragmentation.

Karl Storz was the second-leading competitor in the global powered morcellator market. The company's position is primarily attributed to its leading share of the reposable segment. Karl Storz benefits from its broader presence in endoscopy, laparoscopic instrumentation and minimally invasive surgery, which supports its role in hospitals that prefer reusable or reposable surgical platforms.

BOWA Medical was the third-leading competitor in this segment. Its Ergo 300(R) reposable device uses a reusable handle with disposable blades, giving hospitals a balance between cost control and recurring consumable use. The company also provides blades for other branded morcellators, strengthening its position in the market beyond its own device platform.

Technology and Practice Trends

Containment strategies are one of the most important trends in the powered morcellator market. Manufacturers are increasingly focused on systems and workflows that support contained morcellation to address perceived risks and improve institutional acceptance.

System integration is also shaping product development. Powered morcellators that work efficiently with laparoscopic visualization systems, access devices and containment products can support smoother operating room workflows.

Workflow efficiency remains important because morcellation is often used in procedures where specimen removal can become a limiting step. Devices that simplify setup, improve control and reduce procedure disruption may be preferred by surgeons and operating room teams.

Disposable morcellators remain relevant where hospitals prioritize simplified logistics and reduced reprocessing burden. These products can also support predictable per-case use, which may appeal to facilities focused on standardized workflows.

Reposable morcellators remain important in cost-conscious settings. Reusable handles paired with disposable blades can reduce waste and help manage per-procedure costs while preserving device performance.

Risk perception continues to shape the market. Even when morcellation is clinically appropriate, adoption depends on surgeon comfort, patient selection, institutional policy and the availability of containment-based risk mitigation.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

How large is the global powered morcellator market, and how is it expected to grow through 2032?

How are disposable and reposable powered morcellators performing across global minimally invasive procedures?

How are unit sales, average selling prices and market values changing over time?

Why does morcellation remain necessary in selected gynecological, urological and general surgical procedures?

How are containment strategies and improved visualization shaping product development?

How do alternative procedures affect demand in lower-severity gynecological indications?

How do surgeon training, institutional policy and medico-legal risk perception influence adoption?

Which companies lead the powered morcellator market, and how are LiNA Medical, Karl Storz and BOWA Medical positioned?

The Global Powered Morcellator Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, assess adoption barriers and plan for growth across the global powered morcellator market.